165 related articles for article (PubMed ID: 29274388)
1. IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis.
Rabani M; Wilde B; Hübbers K; Xu S; Kribben A; Witzke O; Dolff S
Clin Immunol; 2018 Mar; 188():45-51. PubMed ID: 29274388
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
[TBL] [Abstract][Full Text] [Related]
4. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B.
Hagn M; Ebel V; Sontheimer K; Schwesinger E; Lunov O; Beyer T; Fabricius D; Barth TF; Viardot A; Stilgenbauer S; Hepp J; Scharffetter-Kochanek K; Simmet T; Jahrsdörfer B
Eur J Immunol; 2010 Jul; 40(7):2060-9. PubMed ID: 20394077
[TBL] [Abstract][Full Text] [Related]
5. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
Mitoma H; Horiuchi T; Kimoto Y; Tsukamoto H; Uchino A; Tamimoto Y; Miyagi Y; Harada M
Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394
[TBL] [Abstract][Full Text] [Related]
7. Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus.
Zhao LD; Liang D; Wu XN; Li Y; Niu JW; Zhou C; Wang L; Chen H; Zheng WJ; Fei YY; Tang FL; Li YZ; Zhang FC; He W; Cao XT; Zhang X
Cell Mol Immunol; 2017 Oct; 14(10):842-849. PubMed ID: 27665947
[TBL] [Abstract][Full Text] [Related]
8. Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients.
Heinemann K; Wilde B; Hoerning A; Tebbe B; Kribben A; Witzke O; Dolff S
Scand J Rheumatol; 2016 Jul; 45(4):312-6. PubMed ID: 26948375
[TBL] [Abstract][Full Text] [Related]
9. Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.
Yoshikawa M; Nakayamada S; Kubo S; Nawata A; Kitanaga Y; Iwata S; Sakata K; Ma X; Wang SP; Nakano K; Saito K; Tanaka Y
Clin Immunol; 2019 Mar; 200():1-9. PubMed ID: 30576845
[TBL] [Abstract][Full Text] [Related]
10. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
11. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
Peng KJ; Xiao LS; Fei Y; Wang SR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
[TBL] [Abstract][Full Text] [Related]
12. CD19
Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
[TBL] [Abstract][Full Text] [Related]
13. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.
Cui HD; Qi ZM; Yang LL; Qi L; Zhang N; Zhang XL; Du SY; Jiang Y
Clin Exp Immunol; 2011 Aug; 165(2):163-71. PubMed ID: 21635228
[TBL] [Abstract][Full Text] [Related]
15. Increased IL-21 Expression Induces Granzyme B in Peripheral CD5(+) B Cells as a Potential Counter-Regulatory Effect in Primary Sjögren's Syndrome.
Papp G; Gyimesi E; Szabó K; Zöld É; Zeher M
Mediators Inflamm; 2016; 2016():4328372. PubMed ID: 26884645
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
17. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.
Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E
Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis.
Xia LP; Li BF; Shen H; Lu J
Scand J Rheumatol; 2015 May; 44(3):200-5. PubMed ID: 25562331
[TBL] [Abstract][Full Text] [Related]
19. Impaired granzyme B-producing regulatory B cells in systemic lupus erythematosus.
Bai M; Xu L; Zhu H; Xue J; Liu T; Sun F; Yao H; Zhao Z; Wang Z; Yao R; Hu F; Su Y
Mol Immunol; 2021 Dec; 140():217-224. PubMed ID: 34749262
[TBL] [Abstract][Full Text] [Related]
20. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
